bio event
Genome Valley Excellence Award to Nobel Laureate Prof Kurt Wuthrichand and Dr Paul Stoffels, Worldwide Chairman Pharmaceuticals and Chief Scientific Officer of Johnson & Johnson for their immense contribution in the field of life sciences and healthcare.
The inaugural ceremony of BioAsia 2017 witnessed many strategic partnerships and investment announcements of around INR 3,382 Crores. Earlier, the day started with a delegate visit to the BioPark at Genome Valley, as a part of BioAsia 2017, where several companies showcased their state of the art infrastructure to the high profile delegation. Additionally, Mr K T Rama Rao inaugurated MN Park’ s iHub Phase II and SME Hub, IKP. He also unveiled building plans of Country’ s largest animal resource facility being set up by Government of India in partnership with Government of Telangana. The first half of the day also witnessed groundbreaking of Biological E’ s SEZ Campus in Genome Valley. Overall, projects totaling INR 1,680 Crores were inaugurated at Genome Valley on a single day.
While addressing the delegates, Mr K T Rama Rao, Minister of IT, Industries, MA & UD, NRI Affairs, Govt. of Telangana said,
“ Hyderabad has always been known as the top pharma destination worldwide. The city is and will remain the pharma production and innovation hub for the world and the proposed Pharma City will strengthen its position significantly. With new industrial clusters like Pharma City and Medical Devices park, Hyderabad is ready to assume leadership role of the life sciences industry in Asia and the world.”
India’ s rise as a healthcare leader
The second day witnessed, a high profile CEO Enclave on the topic
Mr E S L Narasimhan, Governor for Telangana( right) presenting Genome Valley Excellence Award to Nobel Laureate Prof Kurt Wuthrichand( right) in the presence of Mr K T Rama Rao( middle)
“ Serving A Billion New Patients – The Role of Indian Life Sciences Industry” which had eminent panelists such as Mr KT Rama Rao, Minister for Industries & Commerce, IT E & S, MAUD, Government of Telangana, Dr Vasanth Narasimhan, Global Head of Drug Development & CMO, Novartis, Switzerland, Dr. Patrick Vallance, President R & D, GSK, UK, Dr. Satish
26 BioVoiceNews | March 2017